SecBot SecBot
3 ·Filed Jun 10, 2026

VIR

Vir Biotechnology, Inc.
NEUTRAL
Impact 1/10
Horizonmonths Processed5mo ago SEC0001628280-26-042325
Form 3, initial insider ownership statement
Actionable Insight • Neutral

No trading signal from this filing. Monitor future Form 4 filings from Coughlin for any insider buying or selling activity. Given the zero-share initial filing, any future open-market purchase would be a clean insider-buy signal to track.

DirectionNeutral
Confidencehigh
Horizonmonths

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$8.52
T+0 close · Jun 10, 2026 · via day close
Latest settled
+31.22%
T+60 · $11.18
Vs SPY
+27.40%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 11 $8.52entry
  2. T+1 · 5mo ago +1.06%α +0.52% · $8.61
  3. T+5 · 5mo ago +9.15%α +8.72% · $9.30
  4. T+20 · 4mo ago +21.36%α +19.47% · $10.34
  5. T+60 · 2mo ago +31.22%α +27.40% · $11.18
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Timothy Coughlin filed a Form 3 initial statement of beneficial ownership with the SEC, reporting zero shares of Vir Biotechnology common stock. This is a routine filing for a new Section 16 reporting person who has no current holdings, and carries no material trading or financial signal.

Key Facts

  • Form 3 filed by Timothy Coughlin as a new Section 16 reporting person on June 10, 2026
  • Filing reports 0 shares of common stock beneficially owned as of June 9, 2026
  • A power of attorney was also filed, authorizing certain individuals to execute Section 16 filings on Coughlin's behalf

Financial Impact

No financial impact, zero shares reported, no transaction activity.

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
93% bullish (14 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0001628280-26-042325
Document: 0001628280-26-042325-index-headers.html0001628280-26-042325
Document: 0001628280-26-042325-index.html0001628280-26-042325
Document: 0001628280-26-042325.txt0001628280-26-042325

Track record

36 reports on VIR

Performance horizon

4 of 8 bullish or bearish reports moved the stock their way by T+5. Best: +29.79% at T+5 after the Nov 6, 2026 report. 5 of 9 went positive at some point.

Filters
  1. Nov 16, 2026today 424B5 Bearish 5/10 Entry price pending
  2. Nov 13, 20263d ago 8-K Bearish 5/10 Entry $9.92 Now $9.58 +3.43% settles Nov 23
  3. Nov 12, 20264d ago 424B5 Bearish 5/10 Entry $9.96 Now $9.58 +3.82% settles Nov 20
  4. Nov 12, 20264d ago S-3ASR Neutral 3/10 Entry $9.96 Now $9.58 −3.82% settles Nov 20
  5. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $13.15 Now $9.58 −27.15% settles Nov 17
  6. Nov 9, 20267d ago 8-K Bullish 6/10 Entry $13.65 to $9.58 Now $9.58 −29.79% ▼ −29.79% −28.10% vs SPY
  7. Nov 6, 202610d ago SC 13D/A Bearish 5/10 Entry $13.65 to $9.58 Now $9.58 +29.79% ▲ +29.79% +28.10% vs SPY
  8. Nov 4, 202612d ago 8-K Neutral 5/10 Entry $11.02 to $12.12 Now $9.58 −13.07% ▲ +9.98% +6.69% vs SPY
  9. Nov 3, 202613d ago 144 Neutral 2/10 Entry $11.22 to $13.15 Now $9.58 −14.62% ▲ +17.20% +17.79% vs SPY
  10. Nov 2, 202614d ago 144 Neutral 1/10 Entry $11.00 to $13.65 Now $9.58 −12.91% ▲ +24.05% +23.97% vs SPY
Showing 10 of 36

US Market Status

Market Closed · Opens Wed (9h 33m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 10, 2026